Financials
- Fiscal year
- 2025
- Turnover
- €15.3m
- Profit
- €2.7m
- Solvency
- 67.1%
Turnover▲ 15.3%
Net result
20242025
INNOMEDIQ
ActiveSummary
INNOMEDIQ has been active since 2008 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €8.3m and a net result of €2.7m. Equity is growing by ~38% per year across the filed fiscal years. Its solvency ranks better than 79% of 4911 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Overview
Activity
Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
NACE 47741Wholesale of pharmaceutical and medical goods NACE 46460NACE 47740
#1 company by staff growth in Heist-op-den-Berg, Wholesale and retail trade sector1 site
Size
€15.3mturnover 2025
- Staff
- 25.8 FTE
- Equity
- €8.3m
- Profit
- €2.7m
Structure
- Parent
- MEDFI · 100%
- Board
- 2 members
- Holdings
- 1
Accounts filed 10 d late3 of 13 deeds read
Why 95- Liquidity: current ratio 3.06, cash €44,008, halved+ Founded in 2008+ Size: turnover €15.3m, 25.8 FTE, total assets €12.3m+ Profit of €2.7m (FY 2025)Show the evidence
Checked score
Score 2025
95
/ 100
Excellent
Probability in this band: under 0.55%
Better than 77% of its sector peers (NACE 47, small)
Performance against the sector, not lower risk
Financial strength · tick = 2024
Strong
Solvency
92+18
equity 67.1% of total assets
Liquidity
37-14
short-term debt 31.4% · cash 0.4%
Profitability
98+2
return on assets 22.0%
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
11-2024: 0.1%
12-2024: 0.1%● 0.0% vs 11-2024
01-2025: 0.1%● 0.0% vs 12-2024
02-2025: 0.1%▲ +5.2% vs 01-2025
03-2025: 0.1%● 0.0% vs 02-2025
04-2025: 0.1%▲ +14.9% vs 03-2025
05-2025: 0.1%▲ +25.0% vs 04-2025
06-2025: 0.2%▲ +17.2% vs 05-2025highest value
07-2025: 0.1%▼ -53.5% vs 06-2025
08-2025: < 0.1%▼ -39.2% vs 07-2025lowest value
09-2025: < 0.1%● 0.0% vs 08-2025lowest value
10-2025: < 0.1%● 0.0% vs 09-2025lowest value
11-2025: < 0.1%● 0.0% vs 10-2025lowest value
12-2025: < 0.1%● 0.0% vs 11-2025lowest value
01-2026: < 0.1%● 0.0% vs 12-2025lowest value
02-2026: < 0.1%● 0.0% vs 01-2026lowest value
03-2026: < 0.1%● 0.0% vs 02-2026lowest value
04-2026: < 0.1%▲ +2.1% vs 03-2026
05-2026: < 0.1%● 0.0% vs 04-2026
06-2026: < 0.1%▲ +2.0% vs 05-2026
07-2026: 0.1%▲ +22.0% vs 06-2026
08-2026: 0.1%▲ +134% vs 07-2026
09-2026: 0.1%▼ -11.2% vs 08-2026
10-2026: 0.1%● 0.0% vs 09-2026
- Founded in 2008 lowers the probability for this profile
- Liquidity: current ratio 3.06, cash €44,008, halved raises the probability
- Size: turnover €15.3m, 25.8 FTE, total assets €12.3m lowers the probability for this profile
- Profit of €2.7m (FY 2025) lowers the probability
Credit up to €750,000 at 30 days acceptable
Liquidity ample (current ratio 3.06 against 2.14 in 2024; short-term debt: 31.4% and cash: 0.4% of total assets), and 32.9% of the assets are financed with debt.
How it is calculated
The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 47, small). Better than this share of them on solvency 85%, liquidity 40%, profitability 96%, growth against the median 88%. That is performance, not lower risk; the band itself always comes from the probability.
Bankruptcy probability: model pd-v3.202610021621, computed on 04-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.
Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
neutral · A punctual record breaks
This company filed 5 consecutive financial years on time. The year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 10-08-2026, 10 days late. Weigh it accordingly: a break into the 1-to-90-day band measures 1.41% abnormal legal state, below the 1.66% market average. It is a change in behaviour, not evidence of elevated risk.
NBB · 10 filingsDeviation from the deadline
2025
10 d late
2024
1 d early
2023
20 d early
2022
137 d early
2021
6 d early
2020
19 d early
2019
33 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 20 days before the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 25 July (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
05-10-2026 today31-12-2026 close31-07-2027 deadline
- Statutes amendment · Resignations & appointments…Resignations: HOSPIDEX GROUP (director) and…
- Annual accounts filedfiscal year 2025 · full…
- Purpose · RestructuringPermanent representatives: Bart Cauberghe and…
Key points
- Caution: Board changedlatest change 17-12-2025 · 2 in office 2 joined · 2 left View
- Positive: Company by staff growth in Heist-op-den-Berg, Wholesale and…in the Checked rankings #1 View
- Positive: 8 profitable years in a rowprofit 2025: €2.7m 8 years View
- Positive: Equity rose in 2025from €5.6m to €8.3m ▲ 48.8% View
- Controlled by MEDFIultimately: Hospidex Group 100% View
- Merger with CF-SYSTEMmerger on 26-08-2026 2026 View
By topic
Board & ownership
- Board
- 2 members
- Parent
- MEDFI · 100%
Go to Board & ownership
Network & group
- Group
- Hospidex Group
- Subsidiaries
- 1
- Connected companies
- 1
- Mergers and contributions
- 1
1 subsidiary
Timeline
- Events
- 17
- Since
- 2017
- Next accounts
- by 31-07-2027
- 26-08-2026Statutes amendment · Resignations & appointments ·…
- 10-08-2026Annual accounts filed
- 15-06-2026Purpose · Restructuring
Company details
- Sites
- 1
- Legal form
- Public limited company
- Activity
- Retail sale of medical and orthopaedic goods, excluding…NACE 47741
- Founded
- 18-09-2008
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Articles of association
- Provisions read
- 2
- Purpose
- Groot- en detailhandel in medische, orthopedische en paramedische artikelen (NACE 47.74)…
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Is the workforce growing, and do people stay?Employer check Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What other support did companies like this one receive, and it did not?Subsidies
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.